Rock Springs Capital Management LP - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$36,614,045
+39.0%
1,597,1230.0%0.98%
+56.5%
Q2 2023$26,336,558
-7.6%
1,597,1230.0%0.63%
-7.8%
Q1 2023$28,492,674
-44.4%
1,597,123
-9.3%
0.68%
-44.9%
Q4 2022$51,276,389
+18.9%
1,760,8650.0%1.23%
+10.8%
Q3 2022$43,141,000
+640.7%
1,760,865
+25.5%
1.11%
+559.2%
Q2 2022$5,824,000
-59.1%
1,403,298
+13.4%
0.17%
-52.9%
Q1 2022$14,251,000
+127.7%
1,237,026
+97.2%
0.36%
+147.6%
Q4 2021$6,259,000
-21.7%
627,180
+2.5%
0.14%
-13.7%
Q3 2021$7,995,000
-32.7%
612,180
+1.0%
0.17%
-28.5%
Q2 2021$11,871,000
-6.9%
606,280
+1.2%
0.24%
-15.5%
Q1 2021$12,747,000
-12.6%
599,280
+22.2%
0.28%
-10.0%
Q4 2020$14,578,000
+45.0%
490,339
+5.7%
0.31%
+21.2%
Q3 2020$10,057,000
-11.9%
464,086
-9.4%
0.26%
-18.5%
Q2 2020$11,420,000
+50.1%
512,111
+2.4%
0.31%
-0.6%
Q1 2020$7,610,000
-3.9%
500,000
+44.9%
0.32%
+26.0%
Q4 2019$7,921,000
+20.3%
345,000
+13.1%
0.25%
-4.6%
Q3 2019$6,585,000
+27.4%
305,000
+29.8%
0.26%
+40.1%
Q2 2019$5,170,000
-12.9%
235,000
+8.5%
0.19%
-18.3%
Q1 2019$5,934,000
+2.0%
216,5000.0%0.23%
-16.7%
Q4 2018$5,820,000
-7.2%
216,500
+0.7%
0.28%
+21.1%
Q3 2018$6,272,000
-6.7%
215,0000.0%0.23%
-12.4%
Q2 2018$6,721,000
+372.3%
215,000
+200.7%
0.26%
+324.6%
Q1 2018$1,423,000
-31.5%
71,5000.0%0.06%
-35.1%
Q4 2017$2,078,00071,5000.09%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders